ATE216234T1 - Zusammensetzungen aus aminosäure zur behandlung von infektionen - Google Patents

Zusammensetzungen aus aminosäure zur behandlung von infektionen

Info

Publication number: ATE216234T1
Authority: AT; Austria
Prior art keywords: cysteine; amino acid; proportion; acid compositions; treating infections
Prior art date: 1993-10-28

Application number

AT94402420T

Other languages

English (en)

Inventor

Maurice Arnal

Francis Rose

Denis Breuille

Christiane Obled

Original Assignee

Nestle Sa

Agronomique Inst Nat Rech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-28

Filing date

1994-10-27

Publication date

2002-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9452315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE216234(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-10-27 Application filed by Nestle Sa, Agronomique Inst Nat Rech filed Critical Nestle Sa

2002-05-15 Application granted granted Critical

2002-05-15 Publication of ATE216234T1 publication Critical patent/ATE216234T1/de

Links

239000000203 mixture Substances 0.000 title abstract 4
150000001413 amino acids Chemical class 0.000 title abstract 3
208000015181 infectious disease Diseases 0.000 title 1
235000018417 cysteine Nutrition 0.000 abstract 4
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 4
235000001014 amino acid Nutrition 0.000 abstract 2
108010009736 Protein Hydrolysates Proteins 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1
239000002243 precursor Substances 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
235000018102 proteins Nutrition 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

AT94402420T 1993-10-28 1994-10-27 Zusammensetzungen aus aminosäure zur behandlung von infektionen ATE216234T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9312884A FR2711529B1 (fr)	1993-10-28	1993-10-28	Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.

Publications (1)

Publication Number	Publication Date
ATE216234T1 true ATE216234T1 (de)	2002-05-15

Family

ID=9452315

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94402420T ATE216234T1 (de)	1993-10-28	1994-10-27	Zusammensetzungen aus aminosäure zur behandlung von infektionen

Country Status (9)

Country	Link
EP (1)	EP0655244B2 (de)
KR (1)	KR950010884A (de)
AT (1)	ATE216234T1 (de)
CA (1)	CA2134380C (de)
DE (1)	DE69430416T3 (de)
DK (1)	DK0655244T5 (de)
ES (1)	ES2171439T5 (de)
FR (1)	FR2711529B1 (de)
PT (1)	PT655244E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999038507A1 (en) *	1998-01-30	1999-08-05	David George Le Couteur	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
IL150977A (en) *	2000-02-04	2005-09-25	Nestle Sa	Use of protein source for preparation of a nutitional composition for maintaining or improving the synthesis of mucins
EP1302115A1 (de) *	2001-10-16	2003-04-16	Societe Des Produits Nestle S.A.	Verwendung von Cystathionin
EP1715881A1 (de) *	2004-02-12	2006-11-02	Campina Nederland Holding B.V.	Cysteinreiches peptid zur verbesserung der thiol-homöostase
CA2620313C (en) *	2005-06-14	2011-08-02	Nestec S.A.	Nutritional method for elderly people
DE102006018293A1 (de) *	2006-04-20	2007-10-25	Fresenius Kabi Deutschland Gmbh	Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
EP2165713B1 (de)	2008-09-19	2012-11-14	Nestec S.A.	Molke und Verbesserung der Thymusfunktion
WO2011021926A1 (en) *	2009-08-21	2011-02-24	N.V. Nutricia	Regulating the amino acid pool used for the acute-phase protein synthesis
EP2444083A1 (de)	2010-10-21	2012-04-25	Nestec S.A.	Cystein- und Nahrungsmittelaufnahme
WO2024122796A1 (ko) *	2022-12-05	2024-06-13	의료법인 성광의료재단	아스파르트산을 유효성분으로 포함하는 패혈증의 예방 또는 치료용 약학적 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2531204C2 (de) *	1975-07-12	1987-01-22	Fresenius AG, 6380 Bad Homburg	L-Aminosäuregemische für die parenterale oder orale Ernährung
DE2946563C2 (de) *	1979-11-17	1987-04-30	B. Braun Melsungen Ag, 3508 Melsungen	Aminosäurelösung zur parenteralen Infusion
DE3026368A1 (de) *	1980-07-11	1982-02-18	Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München	Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4604286A (en) *	1984-09-17	1986-08-05	Daigo Nutritive Chemicals, Ltd.	Infusion solution for parenteral nutrition
AU605214B2 (en) *	1986-10-24	1991-01-10	Fresenius Kabi Ab	N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
SE8704217D0 (sv) *	1987-10-29	1987-10-29	Vinnars Erik Ab	Aminosyrakomposition for parenteral neringstillforsel
US5224409A (en) †	1991-03-19	1993-07-06	Ashlock Company	Apparatus for producing helical slices
US5214062A (en) †	1992-04-08	1993-05-25	Clintec Nutrition Co.	Method and composition for treating immune disorders, inflammation and chronic infections
AU6060694A (en) †	1993-05-10	1994-11-17	Transcend Therapeutics, Inc	Method for treating acquired immune deficiency syndrome

1993
- 1993-10-28 FR FR9312884A patent/FR2711529B1/fr not_active Expired - Lifetime
1994
- 1994-10-26 CA CA2134380A patent/CA2134380C/en not_active Expired - Lifetime
- 1994-10-27 PT PT94402420T patent/PT655244E/pt unknown
- 1994-10-27 AT AT94402420T patent/ATE216234T1/de not_active IP Right Cessation
- 1994-10-27 ES ES94402420T patent/ES2171439T5/es not_active Expired - Lifetime
- 1994-10-27 DK DK94402420T patent/DK0655244T5/da active
- 1994-10-27 EP EP94402420A patent/EP0655244B2/de not_active Expired - Lifetime
- 1994-10-27 DE DE69430416T patent/DE69430416T3/de not_active Expired - Lifetime
- 1994-10-28 KR KR1019940027823A patent/KR950010884A/ko not_active Withdrawn

Also Published As

Publication number	Publication date
DK0655244T3 (da)	2002-08-05
DE69430416T3 (de)	2009-01-22
DK0655244T5 (da)	2008-10-13
EP0655244B2 (de)	2008-06-11
CA2134380C (en)	2010-06-22
ES2171439T3 (es)	2002-09-16
PT655244E (pt)	2002-08-30
ES2171439T5 (es)	2008-12-01
KR950010884A (ko)	1995-05-15
CA2134380A1 (en)	1995-04-29
DE69430416T2 (de)	2002-12-05
FR2711529B1 (fr)	1996-07-05
EP0655244B1 (de)	2002-04-17
DE69430416D1 (de)	2002-05-23
EP0655244A1 (de)	1995-05-31
FR2711529A1 (fr)	1995-05-05

Legal Events

Date	Code	Title	Description
2002-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69305105D1 (de)	1996-11-07	Zusammensetzungen zur oralen Nahrungsmittelaufnahme mit verbessertem Geschmack
DE69429297D1 (de)	2002-01-17	Zusammensetzung zur Behandlung von Patienten mit Lebererkrankungen
EP0966297A4 (de)	2001-07-11	Verfahren zur regulation gastrointestinaler beweglichkeit
AU6819294A (en)	1994-11-08	Oral drug delivery compositions and methods
FI941500A0 (fi)	1994-03-30	Hormonianalogit joissa on moninkertaisia CTP-lisäkkeitä
ATE165100T1 (de)	1998-05-15	Peptide mit endothelin antagonistischer aktivität, deren herstellung und pharmazeutische zusammensetzungen
ATE187740T1 (de)	2000-01-15	Modifizierte proteine und peptide enthaltende pharmazeutische mittel
NO20023224L (no)	1995-10-02	DNA som koder for et biologisk aktivt fragment av baktericid/permeabilitetsökende protein, fremgangsmåte forfremstilling av dette, samt farmasöytisk preparat inneholdendedette
ATE213499T1 (de)	2002-03-15	Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
DE59810596D1 (de)	2004-02-19	Humanes, rekombinantes interferon-beta mit verbesserter löslichkeit
DE69430416D1 (de)	2002-05-23	Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
FR2741076B1 (fr)	1998-01-30	Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
NO863398L (no)	1987-02-27	Smaksmaskerende preparater.
ATE69164T1 (de)	1991-11-15	Arzneimittel zur behandlung von uraemie.
WO2002058589A3 (en)	2003-07-17	Agents and methods for promoting bone growth
ATE3416T1 (de)	1983-06-15	Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
ATE272399T1 (de)	2004-08-15	Zusammensetzungen aus aminosäuren zur behandlung von herzinsuffizienz
BG103905A (en)	2000-07-31	New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE60001489D1 (de)	2003-04-03	Pharmazeutische zubereitung für die intravenöse oder intramuskuläre verabreichung von octreotid
FI942938A0 (fi)	1994-06-17	Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan
WO1998001474A3 (en)	1998-04-09	Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth
DE60040856D1 (de)	2009-01-02	Lactalbumin zur kurativen Behandlung von Magengeschwüren